{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:23:21Z","timestamp":1788384201753,"version":"build-2803163510"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.taap.2004.08.018","type":"journal-article","created":{"date-parts":[[2004,10,12]],"date-time":"2004-10-12T16:41:28Z","timestamp":1097599288000},"page":"106-113","source":"Crossref","is-referenced-by-count":6,"title":["5-Fluorouracil catabolism to 5-fluoro-5,6-dihydrouracil is reduced by acute liver impairment in mice"],"prefix":"10.1016","volume":"203","author":[{"given":"Federico","family":"Innocenti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romano","family":"Danesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Bocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Natale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Del Tacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2004.08.018_bib1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000138581","article-title":"Oral 5-fluorouracil in psoriasis: pharmacokinetic\u2013pharmacodynamic relationships","volume":"39","author":"Abernethy","year":"1989","journal-title":"Pharmacology"},{"key":"10.1016\/j.taap.2004.08.018_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0378-4274(87)90183-4","article-title":"Locoregional application of 5-fluorouracil to the liver: alteration of pharmacokinetics and bone marrow toxicity in rats with thioacetamide-induced cirrhosis","volume":"36","author":"Aguiar","year":"1987","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.taap.2004.08.018_bib3","first-page":"549","article-title":"Activation and inactivation of cancer chemotherapeutic agents by rat hepatocytes cocultured with human tumor cell lines","volume":"44","author":"Alley","year":"1984","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2004.08.018_bib4","first-page":"351","article-title":"Effect of sublethal liver injury on doxorubicin metabolism","volume":"1","author":"August","year":"1995","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2004.08.018_bib5","first-page":"3032","article-title":"Comparative pharmacokinetic analysis of 5-fluorouracil and its major metabolite 5-fluoro-5,6-dihydrouracil after conventional and reduced test dose in cancer patients","volume":"6","author":"Bocci","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2004.08.018_bib6","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0016-5085(73)80012-5","article-title":"Effect of experimental hepatic injury on the clearance of phenobarbital and paraldehyde","volume":"64","author":"Breen","year":"1973","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2004.08.018_bib7","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0168-8278(05)80144-8","article-title":"Factors affecting the hepatic elimination of oxidized and of glucuronidated high clearance drugs following acute administration of carbon tetrachloride","volume":"20","author":"Callaghan","year":"1994","journal-title":"J. Hepatol."},{"key":"10.1016\/j.taap.2004.08.018_bib8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2165\/00003088-197803040-00006","article-title":"Fluorouracil therapy in patients with carcinoma of the large bowel: a pharmacokinetic comparison of various rates and routes of administration","volume":"3","author":"Chirstophidis","year":"1978","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.taap.2004.08.018_bib9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/cpt196782273","article-title":"The metabolism of uracil-2-14C and the granulocyte response to endotoxin as indicators of the toxicity produced in patients receiving 5-fluorouracil","volume":"8","author":"Creasey","year":"1967","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2004.08.018_bib10","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/0006-2952(86)90041-9","article-title":"Non-linear pharmacokinetics of 5-fluorouracil as described by in vivo behaviour of 5,6 dihydro-5-fluorouracil","volume":"35","author":"de Bruijn","year":"1986","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2004.08.018_bib11","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1023\/A:1012294617392","article-title":"Relationship between 5-fluorouracil disposition, toxicity and dihydropyrimidine dehydrogenase activity in cancer patients","volume":"12","author":"Di Paolo","year":"2001","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.taap.2004.08.018_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00003088-198916040-00002","article-title":"Clinical pharmacology of 5-fluorouracil","volume":"16","author":"Diasio","year":"1989","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.taap.2004.08.018_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1172\/JCI113308","article-title":"Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicity","volume":"81","author":"Diasio","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.taap.2004.08.018_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0959-8049(97)00340-7","article-title":"Pharmacokinetics of anticancer agents in patients with impaired liver function","volume":"34","author":"Donelli","year":"1997","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.taap.2004.08.018_bib15","first-page":"3784","article-title":"A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2\u2032-deoxyuridine and 5-fluorouracil","volume":"38","author":"Ensminger","year":"1978","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2004.08.018_bib16","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/bjc.1992.335","article-title":"No effect of dose, hepatic function, or nutritional status on 5-FU clearance following continuous (5-day), 5-FU infusion","volume":"66","author":"Fleming","year":"1992","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.taap.2004.08.018_bib17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1177\/106002808201600904","article-title":"Clearance of continuously infused 5-fluorouracil in adults having lung or gastrointestinal carcinoma with or without hepatic metastases","volume":"16","author":"Floyd","year":"1982","journal-title":"Drug Intell. Clin. Pharm."},{"key":"10.1016\/j.taap.2004.08.018_bib18","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1200\/JCO.1999.17.4.1105","article-title":"Correlation between uracil and dihydrouracil plasma ratio, fluorouracil (5-FU) pharmacokinetic parameters, and tolerance in patients with advanced colorectal cancer: a potential interest for predicting 5-FU toxicity and determining optimal 5-FU dosage","volume":"17","author":"Gamelin","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2004.08.018_bib19","first-page":"5770","article-title":"pH dependence of 5-fluorouracil uptake observed by in vivo 31P and 19F nuclear magnetic resonance spectroscopy","volume":"51","author":"Guerquin-Kern","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2004.08.018_bib20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/mrm.1910220257","article-title":"A new method for the evaluation of the liver injury by 19F MRS of 5-fluorouracil","volume":"22","author":"Harada","year":"1991","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.taap.2004.08.018_bib21","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/1097-0185(20001101)260:3<228::AID-AR30>3.0.CO;2-S","article-title":"Three-dimensional observations of spatial arrangement of hepatic zonation and vein system in mice and house musk shrews","volume":"260","author":"Hishikawa","year":"2000","journal-title":"Anat. Rec."},{"key":"10.1016\/j.taap.2004.08.018_bib22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s002800050572","article-title":"Opiate effects on 5-fluorouracil disposition in mice","volume":"39","author":"Li","year":"1997","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.taap.2004.08.018_bib23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0378-8741(00)00260-9","article-title":"Hepatoprotective effects of bergenin, a major constituent of mallotus japonicus, on carbon tetrachloride-intoxicated rats","volume":"72","author":"Lim","year":"2000","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.taap.2004.08.018_bib24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0300-483X(00)00193-1","article-title":"Endotoxin pretreatment protects against the hepatotoxicity of acetaminophen and carbon tetrachloride: role of cytochrome P450 suppression","volume":"147","author":"Liu","year":"2000","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2004.08.018_bib25","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0006-2952(93)90141-I","article-title":"Circadian rhythm of orotate phosphoribosyltransferase, pyrimidine nucleoside phosphorylases and dihydrouracil dehydrogenase in mouse liver","volume":"45","author":"Naguib","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2004.08.018_bib26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/phrs.1999.0648","article-title":"Mechanisms for the hepatoprotective action of kolaviron: studies on hepatic enzymes, microsomal lipids and lipid peroxidation in carbon tetrachloride-treated rats","volume":"42","author":"Olatunde Farombi","year":"2000","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.taap.2004.08.018_bib27","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1034\/j.1600-0641.2000.033004555.x","article-title":"Hepatic microvascular features in experimental cirrhosis: a structural and morphometrical study in CCl4-treated rats","volume":"33","author":"Onori","year":"2000","journal-title":"J. Hepatol."},{"key":"10.1016\/j.taap.2004.08.018_bib28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0730-725X(98)00077-0","article-title":"Effects of hepatic impairment on the metabolism of fructose and 5-fluorouracil, as studied in fatty liver models using in vivo 31P-MRS and 19F-MRS","volume":"17","author":"Otsuka","year":"1999","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.taap.2004.08.018_bib29","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0305-7372(82)80012-1","article-title":"Effect of human renal and hepatic disease on the pharmacokinetics of anticancer drugs","volume":"9","author":"Powis","year":"1982","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.taap.2004.08.018_bib30","first-page":"145","article-title":"Carbon tetrachloride hepatotoxicity","volume":"19","author":"Recknagel","year":"1967","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.taap.2004.08.018_bib31","series-title":"Clinical Pharmacokinetics: Concepts and Applications","author":"Rowland","year":"1995"},{"key":"10.1016\/j.taap.2004.08.018_bib32","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF00543978","article-title":"Nonlinear pharmacokinetics characteristics of 5-fluorouracil (5-FU) in colorectal cancer patients","volume":"32","author":"Schaaf","year":"1987","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.taap.2004.08.018_bib33","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF00685119","article-title":"Measurement of in vitro cellular pharmacokinetics of 5-fluorouracil in human and rat cancer cell lines and rat hepatocytes using flow-through system","volume":"27","author":"Spoelstra","year":"1991","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.taap.2004.08.018_bib34","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.3109\/00498259509061911","article-title":"Changes in the metabolism of three model substrates catalysed by different P450 isozymes when administered as a cocktail to the carbon tetrachloride-intoxicated rat","volume":"25","author":"Tanaka","year":"1995","journal-title":"Xenobiotica"},{"key":"10.1016\/j.taap.2004.08.018_bib35","first-page":"651","article-title":"Dihydropyrimidine dehydrogenase activity and fluorouracil pharmacokinetics with liver damage induced by bile duct ligation in rats","volume":"27","author":"Tateishi","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2004.08.018_bib36","first-page":"6956","article-title":"Pharmacokinetics of 5-fluorouracil assessed with a sensitive mass spectrometric method in patients on a dose escalation schedule","volume":"48","author":"van Groeningen","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2004.08.018_bib37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF02897200","article-title":"Tissue distribution of [18F]-5-fluorouracil in mice: effects of route of administration, strain, tumor and dose","volume":"26","author":"Visser","year":"1990","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.taap.2004.08.018_bib38","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s002040050438","article-title":"Time courses of hepatic injuries induced by chloroform and by carbon tetrachloride: comparison of biochemical and histopathological changes","volume":"71","author":"Wang","year":"1997","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.taap.2004.08.018_bib39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1142\/S0192415X04001692","article-title":"The effect of Ginkgo biloba extract (EGb 761) on hepatic sinusoidal endothelial cells and hepatic microcirculation in CCl4 rats","volume":"32","author":"Zhang","year":"2004","journal-title":"Am. J. Chin. Med."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X04003850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X04003850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T09:59:58Z","timestamp":1585907998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X04003850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0041008X04003850"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2004.08.018","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}